- tags:dry eye
Pipeline
FDA accepts Aldeyra's reproxalap DED NDA resubmission
With a new PDUFA data set for April 2024, the company also announced expansions to its option agreement with AbbVie.
Business
Harrow partners with Asembia for expanded branded ophthalmic product access
Partnership aims to simplify the prescribing process and ensure accessibility and affordability for patients; company also reports new Medicare coverage for VEVYE.
Products
myze launches preservative-free daily wipes for lid hygiene
The Daily Wipe is infused with anti-microbial and inflammatory properties such as tea tree oil, hyaluronic acid, chamomile, and euphrasia.
Business
Scope Health purchases Eyetamins supplements
Acquisition features vision health-related products formulated with active ingredients —including AREDS-based and other clinically-backed nutrients.
Products
Optase's Allegro Eye Drops target environmental irritant relief
Preservative-free formulation features a key ingredient in providing a protective hydration shield against harmful environmental irritants for dry eye patients.
Pipeline
Aldeyra resubmits reproxalap NDA for DED
Submission includes recent data from phase 3 dry eye chamber trial supporting the candidate’s acute and chronic activity in reducing symptoms.
Research
Which social determinants of health are tied to dry eye?
Study identifies gap in research on the link between dry eye and healthcare access, educational access, and economic stability.
Products
FDA sends warning letter to Regener-Eyes for cGMP violations, unapproved new drugs
Agency notes significant and unaddressed concerns pertaining to company’s Regener-Eyes PRO and LITE products following June 2023 inspection.
Business
Sonoma Pharmaceuticals and EMC Pharma to co-market expanded eye care product line
Ongoing agreement now involves HOCl-based Ocucyn and Acuicyn eyelid and eyelash cleansers, with the debut targeted for AAO next month.
Pipeline
FDA OKs Palatin's phase 3 DED trials on melanocortin agonist
Patient enrollment for MELODY-2 and MELODY-3 studies is expected to start Q4 2024.
Research
Study identifies Vitamin D benefits for dry eye
Analyses find improved tear production and reduced lid hyperemia were among the advantages.
Products
Bruder to rebrand and distribute Retaine MGD eye drop in the US
The preservative-free drop is expected to hit shelves in early 2025 as Eyeleve MGD.
Products
Lumenis's OptiPLUS delivers clinically significant results for DED
Dry eye expert shares first-hand experience using the first dual-frequency radio frequency technology as a complement to OptiLIGHT.
Pipeline
Eyenovia and Formosa to co-develop clobetasol propionate solution for DED
Partnership will feature FDA-approved eye drop and Optejet delivery system for precision dosing.
Pipeline
Aldeyra reports positive phase 3 data on reproxalap for DED
Dry eye chamber trial meets primary endpoint in hopes of supporting an FDA NDA resubmission by the end of 2024.
Products
OCuSOFT launches new antihistamine drops for ocular allergy relief
NEW OCuSOFT Retaine Allergy features olopatadine HCl ophthalmic solution.
Pipeline
Eyenovia and SGN Nanopharma partner on nanoparticle-based cyclosporine for dry eye
Collaboration will integrate the Optejet topical dispenser with a unique cyclosporine formulation for a more effective treatment.
Pipeline
Eyenovia and Senju to develop chronic dry eye drop-device combo
Collaboration features the Optejet dosing delivery system delivering a corneal epithelial wound healing-ophthalmic solution.
Business
Bausch + Lomb acquires Trukera Medical
Purchase of the former TearLab Corporation includes the ScoutPro Osmolarity System, a point-of-care portable device for osmolarity testing.
Research